Quantum X Labs Launches 50+ Physical Qubits Neutral-Atom Quantum Computer, Targets Thousands Qubit Milestone by End of H1 2027
Tel Aviv, Israel, May 28, 2026 -- Quantum X Labs Inc. (“Quantum X” or the “Company”), an advanced technologies company, today announces the launch of its 50+ qubit neutral-atom quantum computing platform, featuring a proprietary atom cooling technology.
The new platform leverages advanced laser cooling technology combined with dynamically reconfigurable optical tweezer arrays. This architecture enables rapid, high-fidelity loading of large-scale qubit registers, extended coherence times, and native support for high-performance Rydberg-mediated two-qubit gates.
The company’s qubit strategy aims to reach thousands of qubits by end of H1 2027, which is based on logical pathways that include a plan of integrating the company’s pending patented deep transformer decoder (US12294387B2). This AI-based error correction system is tightly coupled with the neutral-atom control stack. Using syndrome-guided decoding, it establishes a low-latency feedback loop that processes the high-fidelity outputs of the Rydberg gates in real time. This unique hardware-AI co-design dramatically reduces computational overhead and establishes a practical pathway toward real-time, fault-tolerant logical qubit operations.
"Our goal is to continue scaling physical qubit counts while building a modular platform with integrated error correction architecture," said Prof. Nir Sharon, the company’s Chief Quantum Technology Scientist. "This 50+ qubit platform is a vital milestone. It gives us the physical environment necessary to implement our proprietary AI-driven error correction and potentially realize efficient, real-time error handling at scale."The platform strengthens Quantum X Labs’ comprehensive quantum portfolio across Quantum Computing, Quantum Software & Simulation, and Quantum Sensing. It is designed to support advanced applications in Aerospace & Defense, clinical trials, processes optimization, nuclear energy, pharmaceuticals, quantum cybersecurity, and other high-impact domains.


